nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat]
nitroglycerin
RxCUI: 207331
What the CMS Formulary Data Shows for nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat]
Per the CMS 2026 Part D formulary file, nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] (RxNorm concept RXCUI 207331, generic name nitroglycerin) appears on 3 distinct formulary files spanning 133 Medicare Part D plan offerings - 2.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 2.3.
Real-world access to nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,348,161 Part D beneficiaries filled nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] in 2023, with total plan-and-beneficiary spending of $46,051,994 and an average per-beneficiary annual cost of $34.16. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] today.
Coverage Details
- Formularies covering
- 3
- Plans covering
- 133
- Coverage rate
- 2.6%
- Tier range
- Tier 1 – Tier 3
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,348,161
- Total spending
- $46,051,994
- Avg per beneficiary
- $34.16
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat]
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T3 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T3 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T3 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T3 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T3 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat]
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] covered by Medicare Part D?
Yes, nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] is covered by 133 Medicare Part D plans (2.6% of all Part D formularies).
What tier is nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] on Medicare Part D plans?
nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] averages Tier 2.3 across Part D plans, ranging from Tier 1 to Tier 3.
Does nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] require prior authorization?
0% of Part D formularies require prior authorization for nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat]?
In 2023, total Medicare Part D spending on nitroglycerin 0.3 MG Sublingual Tablet [Nitrostat] was $46,051,994, covering 1,348,161 beneficiaries. The average spend per beneficiary was $34.16.
Read our methodology - how this data is sourced, computed, and verified.